Liquid Biopsy - Global Market Outlook (2017-2023)

Liquid Biopsy - Global Market Outlook (2017-2023)

  • Published: December 2017
  • ID: SMRC16888

According to Stratistics MRC, the Global Liquid Biopsy market is expected to grow from $310.0 million in 2016 to reach $1201.52 million by 2023 with a CAGR of 21.3%. Increasing research & developments and clinical trials for diagnostics, and technological developments are some of the factors driving the market growth. Moreover, growing prevalence of cancer, increasing awareness about liquid biopsy are the factors fostering the market growth. On the other hand, higher costs and complex regulations are restraining the market growth.

Liquid biopsy tests are used to help find cancer at an early stage. These tests are performed to interpret the molecular aspects of cancer across the healthcare and research settings, such as research laboratories, physicians, pathological and hospitals. The circulating tumor cells leads the market globally with the largest market share and is expected to grow with a highest CAGR during the forecast period. By cancer type, lung cancer segment is expected to witness high growth rate during the forecast period. North America emerged as the major revenue generating region in the global market due to innovative technological developments, and increasing incidence of cancer rates in the Canada and U.S.

Some of the key players in global liquid biopsy market include Roche Diagnostics, Guardant Health, Inc, Illumina, Inc, Biocept, Inc, Myriad Genetics, Inc, Qiagen N.V. , Genomic Health, Inc, Thermo Fisher Scientific Inc , Bio-Rad Laboratories, Inc, Epic Sciences, Exosome, Cynvenio, Guardant Health, Personal Genome Diagnostics and Janssen Diagnostics, LLC.

Clinical Applications Covered:
• Treatment Monitoring
• Recurrence Monitoring
• Early Cancer Screening
• Therapy Selection
 
Product and Services Covered:
• Platforms & Instruments
• Assay Kits & Reagents
• Services

Cancer Types Covered:
• Breast Cancer
• Liver Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Other Cancer Types

Circulating Biomarkers Covered:
• Circulating Tumor DNA (CTDNA)
• Extracellular Vesicles (Evs)
• Circulating Tumor Cells
• Cell-Free DNA
• Exosomes
• Other Circulating Biomarkers

Sample Types Covered:
• Urine
• Blood
• Other Sample Types

End Users Covered:
• Academic and Research Centers
• Hospitals and Physician Laboratories
• Diagnostic centres & Reference Laboratories

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary          
            
2 Preface 
          
 2.1 Abstract          
 2.2 Stake Holders         
 2.3 Research Scope         
 2.4 Research Methodology        
  2.4.1 Data Mining        
  2.4.2 Data Analysis        
  2.4.3 Data Validation        
  2.4.4 Research Approach        
 2.5 Research Sources         
  2.5.1 Primary Research Sources       
  2.5.2 Secondary Research Sources       
  2.5.3 Assumptions        
            
3 Market Trend Analysis         
 3.1 Introduction         
 3.2 Drivers          
 3.3 Restraints         
 3.4 Opportunities         
 3.5 Threats          
 3.6 End User Analysis         
 3.7 Application Analysis        
 3.8 Emerging Markets         
 3.9 Futuristic Market Scenario        
            
4 Porters Five Force Analysis         
 4.1 Bargaining power of suppliers        
 4.2 Bargaining power of buyers        
 4.3 Threat of substitutes        
 4.4 Threat of new entrants        
 4.5 Competitive rivalry         
            
5 Global Liquid Biopsy Market, By Clinical Application       
 5.1 Introduction         
 5.2 Treatment Monitoring         
 5.3 Recurrence Monitoring        
 5.4 Early Cancer Screening         
 5.5 Therapy Selection          
            
6 Global Liquid Biopsy Market, By Product and Service      
 6.1 Introduction         
 6.2 Platforms & Instruments        
 6.3 Assay Kits & Reagents        
 6.4 Services          
            
7 Global Liquid Biopsy Market, By Cancer Type       
 7.1 Introduction         
 7.2 Breast Cancer         
 7.3 Liver Cancer         
 7.4 Lung Cancer         
 7.5 Colorectal Cancer         
 7.6 Prostate Cancer         
 7.7 Other Cancer Types         
            
8 Global Liquid Biopsy Market, By Circulating Biomarker      
 8.1 Introduction         
 8.2 Circulating Tumor DNA (CTDNA)        
 8.3 Extracellular Vesicles (Evs)         
 8.4 Circulating Tumor Cells         
 8.5 Cell-Free DNA          
 8.6 Exosomes         
 8.7 Other Circulating Biomarkers        
            
9 Global Liquid Biopsy Market, By Sample Type       
 9.1 Introduction         
 9.2 Urine          
 9.3 Blood          
 9.4 Other Sample Types         
  9.4.1 Saliva         
  9.4.2 Cerebrospinal fluid        
  9.4.3 Plasma         
            
10 Global Liquid Biopsy Market, By End User       
 10.1 Introduction         
 10.2 Academic and Research Centers        
 10.3 Hospitals and Physician Laboratories       
 10.4 Diagnostic centres & Reference Laboratories      
            
11 Global
Liquid Biopsy Market, By Geography        
 11.1 Introduction         
 11.2 North America         
  11.2.1 US         
  11.2.2 Canada         
  11.2.3 Mexico         
 11.3 Europe          
  11.3.1 Germany         
  11.3.2 UK         
  11.3.3 Italy         
  11.3.4 France         
  11.3.5 Spain         
  11.3.6 Rest of Europe        
 11.4 Asia Pacific         
  11.4.1 Japan         
  11.4.2 China         
  11.4.3 India         
  11.4.4 Australia         
  11.4.5 New Zealand        
  11.4.6 South Korea        
  11.4.7 Rest of South America       
 11.5 South America         
  11.5.1 Argentina        
  11.5.2 Brazil         
  11.5.3 Chile         
  11.5.4 Rest of South America       
 11.6 Middle East & Africa        
  11.6.1 Saudi Arabia        
  11.6.2 UAE         
  11.6.3 Qatar         
  11.6.4 South Africa        
  11.6.5 Rest of Middle East & Africa       
            
12 Key Developments          
 12.1 Agreements, Partnerships, Collaborations and Joint Ventures     
 12.2 Acquisitions & Mergers        
 12.3 New Product Launch        
 12.4 Expansions         
 12.5 Other Key Strategies        
            
13 Company Profiling          
 13.1 Roche Diagnostics          
 13.2 Guardant Health, Inc        
 13.3 Illumina, Inc         
 13.4 Biocept, Inc.         
 13.5 Myriad Genetics, Inc        
 13.6 Qiagen N.V.         
 13.7 Genomic Health, Inc        
 13.8 Thermo Fisher Scientific Inc        
 13.9 Bio-Rad Laboratories, Inc        
 13.10 Epic Sciences         
 13.11 Exosome          
 13.12 Cynvenio          
 13.13 Guardant Health         
 13.14 Personal Genome Diagnostics        
 13.15 Janssen Diagnostics, LLC.        


List of Tables           
1 Global Liquid Biopsy Market Outlook, By Region (2014-2023) (US $MN)      
2 Global Liquid Biopsy Market Outlook, By Clinical Application (2014-2023) (US $MN)     
3 Global Liquid Biopsy Market Outlook, By Treatment Monitoring (2014-2023) (US $MN)    
4 Global Liquid Biopsy Market Outlook, By Recurrence Monitoring (2014-2023) (US $MN)    
5 Global Liquid Biopsy Market Outlook, By Early Cancer Screening (2014-2023) (US $MN)    
6 Global Liquid Biopsy Market Outlook, By Therapy Selection (2014-2023) (US $MN)     
7 Global Liquid Biopsy Market Outlook, By Products & Services (2014-2023) (US $MN)    
8 Global Liquid Biopsy Market Outlook, By Platforms & Instruments (2014-2023) (US $MN)    
9 Global Liquid Biopsy Market Outlook, By Assay Kits & Reagents (2014-2023) (US $MN)    
10 Global Liquid Biopsy Market Outlook, By Services (2014-2023) (US $MN)      
11 Global Liquid Biopsy Market Outlook, By Cancer Type (2014-2023) (US $MN)     
12 Global Liquid Biopsy Market Outlook, By Breast Cancer (2014-2023) (US $MN)     
13 Global Liquid Biopsy Market Outlook, By Liver Cancer (2014-2023) (US $MN)     
14 Global Liquid Biopsy Market Outlook, By Lung Cancer (2014-2023) (US $MN)     
15 Global Liquid Biopsy Market Outlook, By Colorectal Cancer (2014-2023) (US $MN)     
16 Global Liquid Biopsy Market Outlook, By Prostate Cancer (2014-2023) (US $MN)     
17 Global Liquid Biopsy Market Outlook, By Other Cancer Types (2014-2023) (US $MN)    
18 Global Liquid Biopsy Market Outlook, By Circulating Biomarker (2014-2023) (US $MN)    
19 Global Liquid Biopsy Market Outlook, By Circulating Tumor DNA (CTDNA) (2014-2023) (US $MN)   
20 Global Liquid Biopsy Market Outlook, By Extracellular Vesicles (Evs) (2014-2023) (US $MN)    
21 Global Liquid Biopsy Market Outlook, By Circulating Tumor Cells (2014-2023) (US $MN)    
22 Global Liquid Biopsy Market Outlook, By Cell-Free DNA (2014-2023) (US $MN)     
23 Global Liquid Biopsy Market Outlook, By Exosomes (2014-2023) (US $MN)     
24 Global Liquid Biopsy Market Outlook, By Other Circulating Biomarkers (2014-2023) (US $MN)    
25 Global Liquid Biopsy Market Outlook, By Sample Type (2014-2023) (US $MN)     
26 Global Liquid Biopsy Market Outlook, By Urine (2014-2023) (US $MN)      
27 Global Liquid Biopsy Market Outlook, By Blood (2014-2023) (US $MN)      
28 Global Liquid Biopsy Market Outlook, By Other Sample Types (2014-2023) (US $MN)    
29 Global Liquid Biopsy Market Outlook, By Saliva (2014-2023) (US $MN)      
30 Global Liquid Biopsy Market Outlook, By Cerebrospinal fluid (2014-2023) (US $MN)     
31 Global Liquid Biopsy Market Outlook, By Plasma (2014-2023) (US $MN)      
32 Global Liquid Biopsy Market Outlook, By End User (2014-2023) (US $MN)      
33 Global Liquid Biopsy Market Outlook, By Academic and Research Centers (2014-2023) (US $MN)   
34 Global Liquid Biopsy Market Outlook, By Hospitals and Physician Laboratories (2014-2023) (US $MN)   
35 Global Liquid Biopsy Market Outlook, By Diagnostic centres & Reference Laboratories (2014-2023) (US $MN)  
            

NOTE: Tables for North America, Europe, South America, South America and Middle East & Africa are represented in the same manner above.  

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials